NewLead Research

Switzerland · 1 Employees

Computer-assisted design has been for some time a key tool in drug discovery. Today, advances in computer technology allow a qualified expert to carry out sophisticated work in this field, without the need for corporate infrastructure. After long professional work in computer-assisted drug design, I am now offering contract research in Molecular Modelling / Cheminformatics / Bioinformatics I demonstrated in many drug discovery projects that my work creates real value: * lead to clinical candidates * reduce cost and time of synthesis * create intellectual property assets Key is the saving of time and resources. At the onset of a project, I can deliver patentable candidate designs during the period needed to set up the laboratory framework. In more mature projects, I can elucidate the SAR based on sophisticated computational methods, leading to new series with more desirable activity/bioavalability/selectivity/tox profiles, and/or better synthetic accessibility.

查看员工

概述

国家	Switzerland
成立时间	2009
总部	4102, CH
电话号码
网站	http://www.newleadresearch.com
LinkedIn	http://www.linkedin.com/company/newlead-research
Twitter
Facebook
员工数	1
行业	pharmaceuticals,
简介	Computer-assisted design has been for some time a key tool in drug discovery. Today, advances in computer technology allow a qualified expert to carry out sophisticated work in this field, without the need for corporate infrastructure. After long professional work in computer-assisted drug design, I am now offering contract research in Molecular Modelling / Cheminformatics / Bioinformatics I demonstrated in many drug discovery projects that my work creates real value: * lead to clinical candidates * reduce cost and time of synthesis * create intellectual property assets Key is the saving of time and resources. At the onset of a project, I can deliver patentable candidate designs during the period needed to set up the laboratory framework. In more mature projects, I can elucidate the SAR based on sophisticated computational methods, leading to new series with more desirable activity/bioavalability/selectivity/tox profiles, and/or better synthetic accessibility.

查看更多信息

技术

查看所有技术

常见问题